by [email protected] | Jan 4, 2022 | Blog
Real-world data (RWD) and real-world evidence (RWE) are transforming the future of healthcare, including how Health Economics & Outcomes Research (HEOR) reveals the true burden of disease. Clinical trial data and payer-limited datasets are not enough to fully...
by [email protected] | Nov 29, 2021 | Blog
STATinMED RWD Insights Our advisory and linkage services help clients to develop the ideal data lake, sourced with curated data that is aligned with research goals. RWD Insights is STATinMED’s robust, licensed, all-payer medical and pharmacy claims real-world data,...
by [email protected] | Nov 15, 2021 | Blog
Overview A rare disease is defined by the Orphan Drug Act of 1983 as a disease or condition that affects less than 200,000 people in the United States. More than 7,000 diseases fit this definition, affecting a total of 30 million people or about 9% of the US...
by [email protected] | Nov 9, 2021 | Blog
Overview Through real-world evidence (RWE), prescriptions reveal the process and delivery of healthcare. A prescription for a diagnostic test or medication reflects medical practice patterns, healthcare systems, and payer reimbursement for services. Much like...
by [email protected] | Oct 2, 2021 | Blog
When it comes to precision medicine, advances in technologies and treatments have provided near cures for patients with previously incurable cancer, and several more options for those with genetic and immune conditions. Recognized for over a decade, testing of tumors...
by [email protected] | Aug 31, 2021 | Blog, Uncategorized
STATinMED Research is pleased to share the latest updates and links in our summer newsletter, as we celebrate our new brand and company website. Read our recent publications and check out the top blog posts from our RWE authorities. Our door is open. We invite you to...
